Medically Supervised Water-Only Fasting
in the
Treatment of Hypertension
(Goldhamer et al Fasting and Hypertension)
Alan Goldhamer, D.C.
Douglas J. Lisle, Ph.D.
Banoo Parpia, Ph.D.
Cornell University
Corresponding Author
Alan Goldhamer
Phone (707) 586-5555
FAX (707) 586-5554
E-Mail: dracg@worldnet.att.net
Medically Supervised Water-Only Fasting
in the
Treatment of Hypertension
ABSTRACT
Background:
Hypertension-related diseases are the leading causes of morbidity and
mortality in industrially developed societies. Although antihypertensive drugs
are extensively used, dietary and lifestyle modifications also are effective in
the treatment of hypertension. One such lifestyle intervention is the use of medically
supervised, water-only fasting as a safe and effective means of normalizing
blood pressure and initiating health promoting behavioral changes.
Methods: One
hundred seventy-four consecutive hypertensive patients, with blood pressure in
excess of 140 mm Hg systolic and/or 90 mm Hg diastolic (140/90 mm Hg), were
treated in an inpatient setting under medical supervision. The treatment
program consisted of a short pre-fasting period (approximately 2-3 days on
average) during which food consumption was limited to fruits and vegetables,
followed by medically supervised water-only fasting (approximately 10-11 days
on average), and a re-feeding period (approximately 6-7 days on average)
introducing a low-fat, low-sodium, vegan diet.
Results: Almost 90
percent of the subjects achieved blood pressure below 140/90 mm Hg by the end
of the treatment program. The average reduction in blood pressure was 37/13 mm
Hg, with the greatest decrease being observed for subjects with the most severe
hypertension. Stage 3 hypertensives
(those with systolic blood pressure above 180 mg Hg and/or diastolic blood
pressure above 110 mg Hg) experienced an average reduction of 60/17 mm Hg at
the conclusion of treatment. All of the subjects on antihypertensive medication
at entry (6.3% of the total sample) successfully discontinued the use of
medication.
Conclusions: Medically supervised water-only fasting appears to
be a safe and effective means of normalizing blood pressure and may assist in
motivating health promoting diet and lifestyle changes.
Key
Words: Hypertension, water-only fasting, complete fasting, vegan, vegetarian,
non-drug treatment, complementary and alternative medicine
Hypertension-related
diseases are the most common causes of morbidity and mortality among industrially
advanced societies.[1] Each year in
the U.S. there are 500,000 victims of stroke. Hypertension is the major cause
in these incidents, one-third of which are fatal.[2]
Hypertension also is thought to be the most readily controlled preventable
factor in congestive heart failure, a disease involved in more than 400,000
deaths and 2,000,000 events each year in the United States.[3]
Given the magnitude of the causal role played by hypertension in these disease
processes, it is not surprising that many treatment alternatives have received
considerable research investigation.[4]
Surprisingly, the
effectiveness of drug interventions for hypertension has been relatively
disappointing.5-10 More encouraging are
results from both epidemiological and experimental studies suggesting that
alteration of patient lifestyle practices may provide a more promising avenue
of treatment (see Table 1). 11-16
Though medication
may have a net positive benefit for certain patients, the more relevant message
is disquieting: most people who die of coronary artery disease, congestive
heart failure, or stroke do not have BP in ranges sufficiently elevated to
warrant drug treatment.17 Given the
current limitations of drug treatment, the exploration of alternative,
noninvasive methods of BP control should be sought.
There exists an
impressive body of scientific literature indicating substantial effects of
conservative health promoting interventions on BP control.11-16 These interventions include regular
aerobic exercise, bodyweight reduction, smoking cessation, increased dietary
fiber intake, alcoholic beverage restriction, consumption of a vegan-vegetarian
diet, and sodium intake restriction. The advantages of these interventions are
threefold. First, there are virtually no iatrogenic effects. Second, the degree
of BP reduction is in some cases greater than the average reduction of 12/6 mm
Hg commonly obtained by drug therapies.18
Third, not only are these approaches typically devoid of iatrogenic effects,
but each is associated with known comprehensive health benefits.
While the
modification of a single lifestyle variable might not result in BP reductions
comparable to those expected with medication, the use of multiple modifications
undertaken simultaneously has greater promise.16
This paper reports the results of such an effort – wherein multiple lifestyle
variables were controlled in an inpatient environment. Suspension of smoking
and alcoholic beverage use, bodyweight loss, sodium restriction, and dietary
modifications were simultaneously applied in a short-term inpatient experience
which also included a period of medically supervised water-only fasting.
The purpose of this investigation was to
document the effects on BP of water-only fasting together with multiple
lifestyle modifications in a medically supervised controlled environment. The
water-only fast also facilitated bodyweight reduction. After the fasting
process was completed, a low-fat, vegan diet was provided. It was our
expectation that the reduction in BP obtainable with this safe noninvasive
approach might exceed the results typically demonstrated by drug intervention
or by any single lifestyle modification employed independently.
Patients were 174
self-referred adults, consecutively admitted for inpatient care for the
treatment of essential hypertension and other health problems over a period of
12 years (1985 to 1997). A presenting systolic BP of at least 140 mm Hg and/or
diastolic BP of at least 90 mm Hg were required for inclusion. Initial mean BP
levels were 159.1/89.2 mm Hg (Table 2). All patients who met these specific
inclusion criteria during this 12-year period were included in the study.
BP measurements
were made by staff doctors utilizing standard recommended procedures.19 A single BP measurement was taken daily at
morning rounds between 7:30 a.m. and 9:00 a.m. with a portable Baumanometer
Mercury Syphgmomanometer, with the patients in the supine position. Pulse and
BP were measured using the same arm, recording Karotokof sounds 1 and 5.
For at least 2 full
days prior to (or in some cases after) their arrival at the clinic, patients
were instructed to eat a diet consisting exclusively of fresh raw fruits and
vegetables and steamed vegetables. Once this transition diet program and
examination procedures were completed, patients began the water-only fasting
program. BP medications used at entry were phased down gradually. Diuretics
were discontinued when BP levels dropped below 160/104 mm. Dosages for
beta-blockers, angiotensin-converting enzyme inhibitors, and calcium channel
blockers were reduced by approximately 50% every three days. Whenever possible,
medications were phased out prior to initiating the water-only fasting process.
BP medications for all subjects were successfully discontinued with this protocol.
Patients were
administered the water-only fasting regimen in an inpatient environment for
periods ranging from 4 to 28 days. Water-only fasting is the complete
abstinence from all substances – food, tea, juice, non-caloric beverages, etc.,
with the sole exception of distilled water ad libitum (with a minimum of 40
ounces daily). Patients’ activities were restricted, as even moderate activity
during a water-only fast can double energy utilization.20 It
has been observed by these authors, after supervising the fasts of over 4000
patients, that restricted activity appears to minimize the frequency of
orthostatic hypotension, arrythmia, dehydration, and electrolyte
disturbances-side effects reported by others who have encouraged unrestricted
activity during fasting.21
Allowable quiet activities included reading, listening to music, and watching
instructional videos. Patients were also allowed to participate in group
lectures, food preparation demonstrations and classes, and individual medical
and psychological consultations.
Water-only
fasting periods were terminated during periods of relative symptom stability
and after BP normalization. In a few cases, non-clinical issues, such as
limited time available, precipitated the premature termination of fasting. The
water-only fasting period was followed by a period of supervised re-feeding
initiated by the consumption of juices made from fresh raw fruits and
vegetables. Patients received 12 ounces of fresh juice every 3 hours during the
juice phase (approximately one day of juices only for each week of water-only
fasting). The juice phase was then followed by a diet of fresh raw fruits and
vegetables (approximately one day for each week of water-only fasting).
Subsequent to these transitional regimens, a diet of whole natural foods was
introduced. This diet included fresh fruits and vegetables, steamed and baked
vegetables, whole grains and legumes, and very small quantities of raw unsalted
nuts and seeds. The diet specifically excluded any meat, fish, fowl, eggs,
dairy products, or added oil, salt, or sugar. Bread products and other
processed foods were also excluded. Cooked meals were prepared utilizing
recipes exclusively from the Health
Promoting Cookbook.22 After the
juice phase, patients were allowed gradual reintroduction of moderate exercise.
Patients were
cautioned throughout the water-only fasting period regarding orthostatic
hypotension. Patients received twice-daily consultations with a staff doctor.
All fasting protocols were carried out according to the standards set forth by
the International Association of Hygienic Physicians (IAHP).23 The study was approved by the Human
Subjects Committee of the IAHP.
Patients were
additionally monitored with at least twice-weekly urinalyses and once-weekly
blood tests including a complete blood count with differential, a multiple
clinical chemistry panel including electrolytes, liver enzymes, serum proteins,
creatinine, uric acid, bilirubin, glucose, lipids, and erythrocyte sedimentation
rate. Patients with arrythmias were monitored with electrocardiography.
Additional testing was performed when clinically indicated.
Descriptive
statistics, including means and standard deviations, for the outcome variables
of interest were computed for the 174 eligible inpatients at four relevant
time-points: (1) baseline, (2) start of
water-only fasting, (3) end of water-only fasting, and (4) end of
supervised re-feeding (Table 2). The last measurement at the end of the supervised
re-feeding denoted the conclusion of treatment for each subject. Exploratory
analyses revealed no significant differences in systolic or diastolic BP values
by sex or age-group, hence results are not shown separately for age or gender.
In addition, study subjects were classified by JNC criteria into stages of
hypertension at baseline.24 Mean BP was
computed for each stage of hypertension (Table 3). In addition to analyzing the
total treatment response, that is, the response from baseline to the end of
treatment, patient responses to the fasting process alone also were analyzed.
The daily fasting response was computed by dividing the total fasting response
by duration of fast for each patient. Analyses of variance (ANOVA) procedures
were used to test statistical significance of the effect of fasting on BP. The
probability levels of significance reported are based on the two-tailed
t-test. These results are presented in
Table 2. All statistical analyses were conducted using SAS version 6.1.25
Results
The
substantial effects of medically supervised water-only fasting and re-feeding
on BP were statistically highly significant. The water-only fasting period was
preceded by a variable period (average of 2.8 days) of feeding with a low-fat,
plant-based diet, and was followed by a supervised re-feeding period for a
length of time (average of 6.8 days) of at least one-half as long as the
water-only fasting period (average of 10.6 days). The average length of
treatment from admission to discharge was less than 3 weeks (20.2 days). A
small percentage of patients (6.3%) were using antihypertensive drugs upon
entry into the program; all subjects suspended their use of these drugs during
the fast and throughout the supervised re-feeding. Bodyweight over the entire treatment
period (pre-fasting supervised diet, water-only fasting period, and supervised
re-feeding period) decreased by an average of 6.9 kg. During the water-only
fasting period, bodyweight declined an average of 5.9 kg, and mean BMI declined
from 28.7 to 26.5.
BP
dropped during the pre-fasting, water-only fasting, and post-fasting
(supervised re-feeding) periods (Table 2). Most of the decrease occurred during
the water-only fasting period. The overall mean drop of 37.1/13.3 mm Hg is
substantially in excess of the combined effects either of a "vegetarian
diet,” alcohol restriction, sodium restriction, or exercise (Table 1). Moreover, it is also in excess of the
combined 17/13 mm Hg decrease observed in a study utilizing a vegan, low-fat,
low-sodium diet, with exercise.16
The
extent of the drop in BP was strongly dependent on the baseline BP reading at
entry, with more severe cases demonstrating the most striking results (Table
3). When the responses are grouped according to the traditional classification24 of hypertension, 89% of subjects achieved
normotensive status. The final mean BP of these 154 subjects was 117.5/78.7.
These findings
document the effectiveness of water-only fasting and dietary restriction for
the treatment of hypertension. Nearly 9 out of 10 patients (89%) who were
hypertensive at entry were normotensive by the conclusion of their supervised
re-feeding period. All patients who were initially taking anti-hypertensive
medication were off medication by the conclusion of their fast – and remained
off medication throughout the supervised re-feeding period.
Previous
investigations have also noted short-term positive effects of diet and
lifestyle modifications. McDougall et al.16
reported average BP reductions of 17/13 mm Hg for hypertensive patients in a
12-day inpatient program utilizing a vegan-vegetarian diet and daily exercise,
whereas MacGregor et al.12 found average
BP reductions of 16/9 mm Hg for hypertensive patients on a very low-sodium
diet. The present treatment produced an average diastolic BP reduction of 13 mm
Hg, which is consistent with these prior studies. More notable, however, was
the 37 mm Hg decrease in mean systolic BP. Stage 3 hypertensive subjects’ mean
systolic BP was reduced from 194 to 134 mm Hg, a remarkable 60 mm Hg decrease.
The results also suggest that this intervention is relatively safe: no
morbidity was observed at any point in the study for any subject, except for
occasional mild nausea and orthostatic hypotension during the water-only
fasting period. Interestingly, hunger was not reported to be a problem after
the 2nd or 3rd day of water-only fasting.
Twenty (11%) of
the patients, although exhibiting substantial decreases in BP, nonetheless
remained hypertensive at the conclusion of treatment. These partially
responsive patients fasted somewhat fewer days than the 154 fully responsive
subjects (8.9 vs.10.8 days), although this difference did not reach statistical
significance. These partial responders also had a significantly higher average
systolic BP at entry, although, during the fasting period, the rate of systolic
and diastolic reductions actually exceeded (but not significantly) the
reductions of fully responsive subjects. This finding suggests that if these
partial responders had extended their fasts, some or all may have become
normotensive. For some patients with very high initial BP, it may be necessary
to conduct longer fasts, or multiple fasts, to obtain the desired results.
Another notable result is the 5.5/1.8 mm Hg reduction in BP observed
during the supervised re-feeding period (average of 6.8 days). This finding
suggests that the rapid normalization of BP possible with this intervention
strategy may be indefinitely sustainable with a low-sodium vegan diet. This
possibility is consistent with epidemiological findings suggesting that
elevated BP is by no means inevitable for most people.26
In fact, such findings suggest that blood pressure-normalizing diet and
lifestyle modifications, if sustained indefinitely, might be expected to have indefinitely
protective effects. While no
longitudinal studies have examined whether the effects of diet and lifestyle
methods for normalizing BP are as ultimately protective as drug treatment,
there are no in-principle reasons to suspect that they would be less
effective. On the contrary, provided
that such behavioral modifications can be sustained, the protective effects of
diet and lifestyle interventions might be expected to be at least as effective
as current drug treatments, given the absence of iatrogenic effects.
Despite the encouraging results of the present study, many questions
remain unanswered. Further
investigation of the long-term effectiveness of this strategy on hypertension
and its disease sequelae will be required.
At present, we can only offer a limited follow-up report suggesting that
the effect may not be transient. We
have collected follow-up data on 42 of our original 174 subjects, after an
average post-treatment period of 27 weeks.
The mean BP for these subjects was 123/77 mm Hg. While no generalizations can be made from
these limited data, the results are nonetheless suggestive that this approach
may have some sustainable benefits. We
believe that further research efforts may be useful in determining whether
medically supervised water-only fasting and other diet and lifestyle oriented
interventions can be useful adjunctive treatment strategies for the management
of clinical hypertension.
This study was
funded in part by a grant from the ANHS-National Health Association and the
International Association of Hygienic Physicians.
We would like to
thank the following individuals who were instrumental in the successful
collection of data and completion of this study: Jennifer Marano, D.C., Alec
Isabeau, D.C., Erwin Linzner, D.C., Rick Dina, D.C., Ron Cridland, M.D., David
Aukamp, D.C., Chris Postma, D.C., Joel Fuhrman, M.D., Roger Walker, D.C., Kelli
Greene, D.C., Danny Keret, M.D., Ben Kim, D.C., Harold Goldhamer, Joan Chilton,
and James Lennon.
Table 1. Results of Previous Studies Reporting Blood Pressure
Reductions Associated with Various Intervention Strategies
|
Systolic (mm Hg) |
Diastolic (mm Hg) |
Source |
Bodyweight Loss* |
- 1.6 |
- 1.3 |
Staessen et al.
(198911)# |
Sodium
Restriction† |
- 16.0 |
- 9.0 |
MacGregor et
al. (198912) |
Vegetarian/High-Fiber
Diet |
- 2.8 |
- 1.1 |
Appel et al.
(199713) |
Alcohol Intake‡ |
- 4.8 |
- 3.3 |
Puddey et al.
(199214) |
Exercise§ |
- 6.0-7.0 |
- 6.0-7.0 |
Arroll and
Beaglehole (199215)# |
Combination of Low-fat, Low-salt, Vegan Diet, and
Exercise |
- 17.0 |
- 13.0 |
McDougall et
al. (199516) |
Effects of Standard
Antihypertensive Drug Treatment |
- 12.0 |
- 6.0 |
Kaplan (199817) |
*BP reduction per kg of bodyweight loss.
†Sodium intake reduced from 200 mmoles/day to
50 mmoles/day.
‡Reduction of alcohol intake from 440 ml to
66 ml/week.
§Average of 3 times per week of aerobic
activity.
#Meta-analysis.
Table 2. Average Blood Pressure (mm Hg),
Weight (kg), and Body Mass Index (BMI)
for a
Sample of 174 Hypertensive Patients Measured at Four Time Points Through a
Variables |
Results Mean ± SD |
Number of
subjects |
174 |
Age (years) |
58.6 ± 14.0 |
1 Baseline
|
|
Systolic BP (mm
Hg) |
159.1 ± 19.4a |
Diastolic BP
(mm Hg) |
89.2 ± 10.2 a |
Weight (kg) |
78.4 ± 17.2 a |
BMI |
28.9 ± 5.9 a |
Pre-fasting
period (days) |
2.8 ± 4.8 |
2 Start of
water-only fasting
|
|
Systolic BP (mm
Hg) |
148.5 ± 18.7b |
Diastolic BP
(mm Hg) |
85.9 ± 11.0 b |
Weight (kg) |
78.0 ± 17.4 a |
BMI |
28.7 ± 5.9 a |
Fasting period
(days) |
10.6 ± 5.6 |
3 End of
water-only fasting
|
|
Systolic BP (mm
Hg) |
127.4 ± 16.1c |
Diastolic BP
(mm Hg) |
77.7 ± 8.8 c |
Weight (kg) |
72.1 ± 16.1 b |
|
|
BMI |
26.5 ± 5.5 b |
4 End of supervised re-feeding (End of treatment program) |
|
Systolic BP (mm
Hg) |
121.9 ± 17.8d |
Diastolic BP
(mm Hg) |
75.7 ± 8.7 c |
Weight (kg) |
71.7 ± 16.6 b |
BMI |
26.5 ± 5.8 b |
|
|
Post-fasting re-feeding period (days) |
6.8 ± 3.3 |
Duration of total
treatment program (days) |
20.2 ± 4.6 |
a,b,c,dComparable means
in each of the four time periods were tested for statistical significance using
the ANOVA procedure based on Duncan’s Multiple Range test. Means with a
different letter are significantly different (p<0.05) for each variable of
interest across each of the four time-points.
Table 3: Effects of Water-Only Fasting and Supervised Re-feeding on
Subjects by Stage of
Hypertension* at Start of Treatment
Hypertension Category * |
N |
Baseline SBP/DBP (mm Hg) |
Start of
Fasting SBP/DBP (mm Hg) |
End of Fasting SBP/DBP (mm Hg) |
End of
Re-feeding SBP/DBP (mm Hg) |
Total Change SBP/DBP (mm Hg) |
Stage 1 |
92 |
145.5/ 85.7 |
139.0/ 82.2 |
121.9/ 75.7 |
116.1/ 74.3 |
-29.4/ -11.4 |
Stage 2 |
57 |
165.8/ 91.7 |
154.1/ 88.9 |
130.9/ 79.1 |
125.9/ 76.9 |
-39.9/ -14.7 |
Stage 3 |
25 |
193.8/ 96.4 |
170.9/ 92.4 |
140.0/ 81.9 |
134.2/ 79.4 |
-59.6/ -16.9 |
Total |
174 |
159.1/ 89.2 |
148.5/ 85.9 |
127.5/ 77.7 |
121.9/ 75.9 |
-37.1/ -13.3 |
* Stages as
defined by JNC VI. Stage 1 is defined by SBP of 140-159 mm Hg and/or DBP of
90-99 mm Hg. Stage 2 is defined by SBP of 160-179 mm Hg and/or DBP of 100-109
mm Hg. Stage 3 is defined by SBP > 180 mm Hg, and/or DBP > 110 mm Hg.When
the systolic and diastolic BP fall into different categories, the higher
category defines BP status.
[1] Stamler J,
Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and
cardiovascular risks. US population data. Arch Intern Med 1993;153:598-615.
2Taylor TN, Davis PH, Torner JC, Homes J, Meyer JW, Jacobson MF.
Lifetime cost of stroke in the United States. Stroke 1996;27:1459-66.
3 Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac
failure. Br Heart J 1994;72(Suppl);S3-S9.
4 Kaplan NM. Clinical
hypertension, 7th ed., Williams and Wilkens, Baltimore, Md.:
1998;133-263.
5 Hoes A, Grobbee D, Labsen J. Does drug treatment improve survival?
Reconciling the trials in mild-to-moderate hypertension. J Hypertens
1995;13:805-11.
6 Kaplan NM. Hypertension: prevalence, risks, and effect of therapy. Ann
Intern Med 1983;98:705-9.
7 Cruickshank JM. Benefits and potential harm of lowering high blood
pressure. Lancet 1987;1:581-84.
8 Jachuck SJ, Bierley H, Jachuck S, Willcox PM. The effect of
hypotensive drugs on the quality of life. J Roy Coll Gen Pract 1982;32:103-5.
9 Isles CG, Walker LM, Beevers GD, Brown I, Cameron HL, Clarke J,
Hawthorne V, Hole D, Lever AF, Robertson JWK, Wapshaw JA. Mortality in patients
of the Glasgow Blood Pressure Clinic. J Hypertens 1986;4:141-56.
10 Kannel WH, Cupples LA, D’Angostino RB, Stokes J III. Hypertension,
antihypertensive treatment, and sudden coronary death. The Framingham Study. Hypertension
1988;11(Suppl II):II-45-II-50.
11Staessen J, Fagard R, Lijnen P, Amery A. Body weight, sodium intake and
blood pressure. J Hypertens 1989;7:S19-S23.
12 MacGregor G, Markandu N, Sagnella G, Singer D, Cappuccio F.
Double-blind study of three sodium intakes and long-term effects of sodium
restriction in essential hypertension. Lancet
1989;2:1244-47.
13 Appel L, Moore T, Obarzanek E, Vollmer W, Svetkey L, Sacks F, Bray G,
Vogt T, Cutler J, Windhauser M, Pao-Hwa L, Karanja N. A clinical trial of the effects
of dietary patterns on blood pressure. NEJM
1997;336:16:1117-24.
14 Puddey I, Parker M, Beilin L, Vandongen R, Masarei J. Effects of
alcohol and caloric restrictions on blood pressure and serum lipids in
overweight men. Hypertension 1992;20:4:533-41.
15 Arroll B, Beaglehole R. Does physical activity lower blood pressure? A
critical review of the clinical trials. J Clin Epidemiol 1992;45:439-47.
16 McDougall J, Litzau K, Haver E, Saunders V, Spiller R, Spiller G.
Journal of the American College of Nutrition, 1995;14:5:491-96.
17 Kaplan NM. Clinical Hypertension, 7th ed.,
Williams and Wilkens, Baltimore, Md.:1998;13-14.
18 Kaplan NM. Clinical
Hypertension, 7th ed., Williams and Wilkens, Baltimore,
Md.:1998;143.
19 The clinical measurement of
blood pressure, W.A. Baum Co, Copiague, NY.: 1987;11-14.
20 Cahill GF. Famine Symposium—Physiology of acute starvation in man.
Ecology of food and nutrition 1978;6:221.
21 Consolazio, C.F., Matoush, L.O., Johnson, H.L., Nelson, R.A., &
Krzywicki, H.J. Metabolic aspects of acute starvation in normal humans (10
days).American journal of clinical nutrition 1967;20:7:672-83.
22 Goldhamer A. The health
promoting cookbook, Book Publishing Co, Summertown, TN.: 1996;7-178.
23 International Association of Hygienic Physicians. Standards of practice, Youngstown, OH.:1997.
24 Joint National Committee on Detection, Evaluation, and Treatment of
High Blood Pressure (JNC VI). The Sixth Report of the Joint National Committee
on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch
Intern Med 1997;157:2413-46.
25 SAS Institute Inc. Language and
procedures guides: usage 1 and 2. 1 ed., SAS Institute Inc., Cary, NC:1991.